指南与共识儿科与产科急症复苏、休克与脓毒症

新型平板应用减少儿科心脏骤停期间指南偏差的有效性:一项随机临床试验

Effectiveness of a Novel Tablet Application in Reducing Guideline Deviations During Pediatric Cardiac Arrest: A Randomized Clinical Trial.
指南 / 共识 · JAMA Netw Open · 2023-08-01
一句话结论模拟院内儿科心脏骤停中,PediAppRREST应用较PALS纸质卡和无辅助均显著减少指南偏差并提高团队临床表现,但其他次要结局无显著差异。

这项在4家意大利大学医院开展的多中心3组模拟随机临床试验,纳入100个团队(300名住院医师),比较PediAppRREST应用、PALS纸质认知辅助卡和无认知辅助在不可电击儿科心脏骤停模拟场景中的效果。主要结局为基于指南推荐的15项清单偏离数,PediAppRREST组较PALS对照组平均差异-3.0(95%CI -4.0至-1.9,P<.001),较无辅助对照组平均差异-2.6(95%CI -3.6至-1.5,P<.001)。临床表现工具评分PediAppRREST组也显著更高(vs PALS对照平均差异1.4,95%CI 0.4至2.3,P=.002;vs 无辅助对照平均差异1.1,95%CI 0.2至2.1,P=.01)。其他次要结局组间无显著差异。结论认为该应用可减少指南偏差并改善团队临床表现。

要点

  • 模拟院内不可电击儿科心脏骤停中,PediAppRREST组指南偏离数较PALS纸质卡组平均少3.0项(95%CI -4.0至-1.9,P<.001)。
  • PediAppRREST组指南偏离数较无认知辅助组平均少2.6项(95%CI -3.6至-1.5,P<.001)。
  • PediAppRREST组临床表现工具评分较PALS组平均高1.4分(95%CI 0.4至2.3,P=.002),较无辅助组平均高1.1分(95%CI 0.2至2.1,P=.01)。
  • 胸外按压质量、团队领导者感知工作负荷等其他次要结局在各研究组间无显著差异。
  • 研究为模拟场景,参与者为儿科、急诊医学和麻醉学住院医师,结论需在真实临床中进一步验证。

适用人群与场景

  • 参与模拟院内儿科心脏骤停管理的儿科、急诊医学和麻醉学住院医师团队。
  • 所有团队管理相同的标准化不可电击儿科心脏骤停模拟场景。

处置流程与药物剂量

  • 干预组使用PediAppRREST平板应用辅助管理。
  • 对照组分别使用PALS纸质认知辅助卡或不使用任何认知辅助。

研究设计与关键结果

  • 多中心3组模拟随机临床试验,2020年9月至2021年12月在意大利4所大学医院(帕多瓦、佛罗伦萨、罗马、诺瓦拉)开展,纳入100个团队共300名参与者(平均年龄29.0岁,SD 2.2;女性195名,65%),按意向性分析。
  • 参与者包括儿科住院医师210名(70%)、麻醉学住院医师48名(16%)、急诊医学住院医师42名(14%),各组基线特征无统计学差异。
  • 主要结局指南偏离数:PediAppRREST组较PALS对照组平均差异-3.0(95%CI -4.0至-1.9,P<.001),较无辅助对照组平均差异-2.6(95%CI -3.6至-1.5,P<.001)。
  • 临床表现工具评分:PediAppRREST组较PALS对照组平均差异1.4(95%CI 0.4至2.3,P=.002),较无辅助对照组平均差异1.1(95%CI 0.2至2.1,P=.01)。
  • 其他次要结局(胸外按压质量、团队领导者感知工作负荷)在各研究组间无显著差异。

证据类型、等级与局限

  • 证据类型:多中心3组模拟随机临床试验。
  • 试验注册号:ClinicalTrials.gov NCT04619498。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在模拟儿科心脏骤停团队复苏中,使用PediAppRREST应用可能减少指南偏差并改善团队临床表现;该结论来自模拟场景,作者认为需在真实临床环境中进一步验证。

指南或共识出处

  • PediAppRREST应用;PALS纸质认知辅助卡。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Deviations from international resuscitation guidelines during the management of pediatric cardiac arrest are frequent and affect clinical outcomes. An interactive tablet application (app), PediAppRREST, was developed to reduce guideline deviations during pediatric cardiac arrest.

OBJECTIVE: To assess the effectiveness of PediAppRREST in improving the management of simulated in-hospital pediatric cardiac arrest.

DESIGN, SETTING, AND PARTICIPANTS: This multicenter 3-group simulation-based randomized clinical trial was conducted from September 2020 to December 2021 at 4 Italian university hospitals (Padua, Florence, Rome, Novara). Participants included residents in pediatrics, emergency medicine, and anesthesiology. Analyses were conducted as intention-to-treat. Data were analyzed from January to June 2022.

INTERVENTIONS: Teams were randomized to 1 of 3 study groups: an intervention group that used the PediAppRREST app; a control group that used a paper-based cognitive aid, the Pediatric Advanced Life Support (PALS) pocket card; and a control group that used no cognitive aids. All the teams managed the same standardized simulated scenario of nonshockable pediatric cardiac arrest.

MAIN OUTCOMES AND MEASURES: The primary outcome was the number of deviations from guidelines, measured by a 15-item checklist based on guideline recommendations. The main secondary outcomes were quality of chest compressions, team clinical performance (measured by the Clinical Performance Tool), and perceived team leader's workload. Study outcomes were assessed via video reviews of the scenarios.

RESULTS: Overall 100 teams of 300 participants (mean [SD] age, 29.0 [2.2] years; 195 [65%] female) were analyzed by intention-to-treat, including 32 teams randomized to the PediAppRREST group, 35 teams randomized to the PALS control group, and 33 teams randomized to the null control group. Participant characteristics (210 pediatric residents [70%]; 48 anesthesiology residents [16%]; 42 emergency medicine residents [14%]) were not statistically different among the study groups. The number of deviations from guidelines was significantly lower in the PediAppRREST group than in the control groups (mean difference vs PALS control, -3.0; 95% CI, -4.0 to -1.9; P < .001; mean difference vs null control, -2.6; 95% CI, -3.6 to -1.5; P < .001). Clinical Performance Tool scores were significantly higher in the PediAppRREST group than control groups (mean difference vs PALS control, 1.4; 95% CI, 0.4 to 2.3; P = .002; mean difference vs null control, 1.1; 95% CI, 0.2 to 2.1; P = .01). The other secondary outcomes did not significantly differ among the study groups.

CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, the use of the PediAppRREST app resulted in fewer deviations from guidelines and a better team clinical performance during the management of pediatric cardiac arrest.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04619498.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Corazza F, Arpone M, Tardini G, et al. Effectiveness of a Novel Tablet Application in Reducing Guideline Deviations During Pediatric Cardiac Arrest: A Randomized Clinical Trial. JAMA Netw Open. 2023. PMID: 37535352. doi:10.1001/jamanetworkopen.2023.27272

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。